Read More

Senti Bio Announces New Strategic Collaboration With Celest Therapeutics For Clinical Development Of SENTI-301A In China; Senti Bio Eligible To Receive Up To $156M In Milestones And Royaltie

– Celest to lead clinical development with technical support from Senti Bio – – First patient expected to be enrolled in China in 1H 2024 –– Senti Bio eligible to receive up to $156 million in milestones and

SNTI

Read More

Israel-Hamas Conflict, Day 31: Biden, Netanyahu Talk Humanitarian Ceasefire Options, Israel’s Foreign Affairs Minister Says ‘Shame On You!’In Response To UN Chief’s Call For Gaza Humanitarian Aid

Discussions between the U.S. and Israel regarding a humanitarian ceasefire in the war between Israel and Hamas are just beginning, says National Security Council spokesman.

EIS